Continued backing of EnClear Therapies' neuro-oncology CSF management platform alongside Founders Fund and Amgen Ventures.
EnClear Therapies aims to improve and extend the lives of patients suffering from central nervous system (CNS) disorders through precision dosing using their proprietary EnTrega CSF Platform
EnClear Therapies aims to improve and extend the lives of patients suffering from central nervous system (CNS) disorders through precision dosing using their proprietary EnTrega CSF Platform.